Ananda Developments plc (AQSE: ANA), a company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of chronic, complex inflammatory pain conditions, is pleased to announce that its wholly owned subsidiary MRX Medical Limited, has filed four patent applications with the UK government’s Intellectual Property Office. The applications cover three
Ananda Developments plc (AQSE: ANA), a company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of chronic, complex inflammatory pain conditions, is pleased to announce that its wholly owned subsidiary MRX Medical Limited, has filed four patent applications with the UK government’s Intellectual Property Office. The applications cover three […]
Cannabis Law Report
You must log in to post a comment.